Xinli Jiang1, Huijie Ma2, Chunguang Li3, Yue Cao3, Yan Wang3, Yi Zhang2, Yan Liu3. 1. Department of Ophthalmology, the Third Hospital of Hebei Medical University, Shijiazhuang, China. 2. Department of Physiology, Hebei Medical University, Shijiazhuang, China. 3. Department of Endocrinology, the Third Hospital of Hebei Medical University, Shijiazhuang, China.
Abstract
BACKGROUND: Evaluations of stress-induced cardiac functional alterations in adults after neonatal glucocorticoid (GC) treatment have been limited. In the present study, we evaluated adult cardiac functional recovery during postischemic reperfusion and measured cardiac gene expression involved energy metabolism in rats neonatally treated with dexamethasone (DEX). METHOD: Male Wistar rats were injected DEX in first 3 d after birth and controls were received saline (SAL). At 24 wk of age, insulin tolerance tests were performed, plasma lipid levels were measured, and left ventricular function and myocardial infarct size were evaluated. Expressions of genes involved in cardiac energy metabolism were measured by quantitative real-time polymerase chain reaction (PCR) and western blot. RESULTS: In 24-wk-old rats, neonatal DEX administration caused dyslipidemia, impaired cardiac recovery function and increased size of infarction, decreased cardiac expression of glucose transporter 4(GLUT4), peroxisome proliferative-activated receptor gamma coactivator 1α (PGC-1α) and ratios of phospho-forkhead box O1/forkhead box O1 (p-FoxO1/FoxO1) and phospho AMP-activated protein kinase/AMP-activated protein kinase (p-AMPK/AMPK) but increased pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) expression compared with controls. CONCLUSION: Neonatal DEX administration impairs cardiac functional recovery during reperfusion following ischemia in 24-wk-old rats. Reduced cardiac glucose utilization may contribute to the long-term detrimental effects caused by neonatal DEX treatment.
BACKGROUND: Evaluations of stress-induced cardiac functional alterations in adults after neonatal glucocorticoid (GC) treatment have been limited. In the present study, we evaluated adult cardiac functional recovery during postischemic reperfusion and measured cardiac gene expression involved energy metabolism in rats neonatally treated with dexamethasone (DEX). METHOD: Male Wistar rats were injected DEX in first 3 d after birth and controls were received saline (SAL). At 24 wk of age, insulin tolerance tests were performed, plasma lipid levels were measured, and left ventricular function and myocardial infarct size were evaluated. Expressions of genes involved in cardiac energy metabolism were measured by quantitative real-time polymerase chain reaction (PCR) and western blot. RESULTS: In 24-wk-old rats, neonatal DEX administration caused dyslipidemia, impaired cardiac recovery function and increased size of infarction, decreased cardiac expression of glucose transporter 4(GLUT4), peroxisome proliferative-activated receptor gamma coactivator 1α (PGC-1α) and ratios of phospho-forkhead box O1/forkhead box O1 (p-FoxO1/FoxO1) and phospho AMP-activated protein kinase/AMP-activated protein kinase (p-AMPK/AMPK) but increased pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) expression compared with controls. CONCLUSION: Neonatal DEX administration impairs cardiac functional recovery during reperfusion following ischemia in 24-wk-old rats. Reduced cardiac glucose utilization may contribute to the long-term detrimental effects caused by neonatal DEX treatment.
Authors: Yun Yong Lee; Hwa-Jung Lee; Seung-Sook Lee; Jae Soo Koh; Cheng Ji Jin; Sung-Hye Park; Ka Hi Yi; Kyong Soo Park; Hong Kyu Lee Journal: Br J Nutr Date: 2011-05-31 Impact factor: 3.718
Authors: Pavan K Battiprolu; Berdymammet Hojayev; Nan Jiang; Zhao V Wang; Xiang Luo; Myriam Iglewski; John M Shelton; Robert D Gerard; Beverly A Rothermel; Thomas G Gillette; Sergio Lavandero; Joseph A Hill Journal: J Clin Invest Date: 2012-02-13 Impact factor: 14.808
Authors: Yan Liu; Harry van Goor; Rick Havinga; Julius F W Baller; Vincent W Bloks; Feike R van der Leij; Pieter J J Sauer; Folkert Kuipers; Gerjan Navis; Martin H de Borst Journal: Am J Physiol Renal Physiol Date: 2008-01-30
Authors: Jeevan Nagendran; Thomas Pulinilkunnil; Petra C Kienesberger; Miranda M Sung; David Fung; Maria Febbraio; Jason R B Dyck Journal: J Mol Cell Cardiol Date: 2013-08-12 Impact factor: 5.000